Immunological effects of recombinant human erythropoietin on end-stage renal disease pediatric and adult patients.
Salvati
F
F
Liani
M
M
La Torre
M
M
Golato
M
M
Di Sciascio
N
N
Pietrzyk
J
J
Dyras
P
P
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D002648:Child; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D011994:Recombinant Proteins; D004921:Erythropoietin